FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 62 filers reported holding FOGHORN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,330 | -66.0% | 4,066 | -52.1% | 0.00% | – |
| Q2 2023 | $59,713 | +3.9% | 8,482 | -8.5% | 0.00% | – |
| Q1 2023 | $57,487 | +67.2% | 9,272 | +72.1% | 0.00% | – |
| Q4 2022 | $34,382 | +1046.1% | 5,389 | +1368.4% | 0.00% | – |
| Q3 2022 | $3,000 | -62.5% | 367 | -34.7% | 0.00% | – |
| Q2 2022 | $8,000 | -87.3% | 562 | -86.3% | 0.00% | – |
| Q1 2022 | $63,000 | -74.8% | 4,106 | -62.4% | 0.00% | – |
| Q4 2021 | $250,000 | – | 10,914 | +28621.1% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 38 | -98.3% | 0.00% | – |
| Q1 2021 | $30,000 | -60.5% | 2,251 | -39.9% | 0.00% | – |
| Q4 2020 | $76,000 | – | 3,747 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 1,261,261 | $13,458,000 | 4.37% |
| Birchview Capital, LP | 314,143 | $3,352,000 | 2.00% |
| Flagship Pioneering Inc. | 12,674,120 | $135,233,000 | 1.73% |
| Monashee Investment Management LLC | 530,581 | $5,661,000 | 0.68% |
| Artal Group S.A. | 1,720,720 | $18,360,000 | 0.37% |
| Alphabet Inc. | 500,901 | $5,345,000 | 0.11% |
| Casdin Capital, LLC | 216,216 | $2,307,000 | 0.06% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 84,000 | $896,000 | 0.01% |
| NewSquare Capital LLC | 5,000 | $53,000 | 0.01% |
| FMR LLC | 2,540,434 | $27,106,000 | 0.00% |